Companies: 10,795·Total market cap: $144.5T
Proto Script Pharmaceutical Corp.

Proto Script Pharmaceutical Corp.

PSCROTCIndustrials● Active
$0.00
+$0.00(+0.00%)
Market Cap$9828
P/E Ratio—
52W High$0.0011
52W Low$0.0001
SEC Filings

Proto Script Pharmaceutical Corp. (PSCR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001521420 · PSCR · OTC · as of Jun 10, 2026

Filing snapshot

79
Total Filings
NT 10-K
Latest Form
2018-03-30
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001521420 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2017-10-19
Fiscal Year End
Oct 19, 2017
Accession No.
0001640334-17-002207
Primary Document
pscr_10ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001521420 · Accession 0001640334-17-002207

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2018-03-08
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2017-10-30Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
NT 10-KNT 10-K
FORM NT 10-K NOTICE OF LATE ANNUAL FILING
2018-03-30
View
10-QQuarterly Report
FORM 10-Q
2018-03-08
View
10-QQuarterly Report
FORM 10-Q
2018-01-17
View
10-QQuarterly Report
FORM 10-Q
2017-11-22
View
8-KCurrent Report
FORM 8-K
2017-10-30
View
10-K/AAnnual Report (Amended)
FORM 10-K/A
2017-10-19
View
8-KCurrent Report
FORM 8-K
2017-10-19
View
10-KAnnual Report
FORM 10-K
2017-09-20
View
NT 10-KNT 10-K
NOTICE OF LATE FILING
2017-03-31
View
8-KCurrent Report
FORM 8-K CURRENT REPORT
2017-02-15
View
UPLOADUPLOAD
UPLOAD
2017-01-11
View
10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT
2017-01-06
View
10-Q/AQuarterly Report (Amended)
FORM 10-Q/A AMENDED QUARTERLY REPORT
2016-12-07
View
UPLOADUPLOAD
UPLOAD
2016-11-22
View
10-QQuarterly Report
FORM 10-Q QUARTERLY REPORT
2016-11-18
View
Showing 1–15 of 79 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001521420  |  Exchange: OTC · Industrials

Proto Script Pharmaceutical Corp. (OTC: PSCR) has submitted 79 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Industrials sector company with CIK 0001521420, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Proto Script Pharmaceutical Corp.'s most comprehensive regulatory disclosure. The most recent Proto Script Pharmaceutical Corp. 10-K was filed on 2017-10-19 for fiscal year ending 2017. Historical PSCR 10-K annual reports are available from 2011 through 2017.

Investors researching Proto Script Pharmaceutical Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Industrials
SYEV SEC Filings →BRYN SEC Filings →CESX SEC Filings →AMCT SEC Filings →MHHC SEC Filings →FIFG SEC Filings →RBSY SEC Filings →ORGH SEC Filings →
→ PSCR Financials→ PSCR Earnings→ PSCR Insider Trades

Frequently Asked Questions

PSCR SEC Filings · 8 questions

Proto Script Pharmaceutical Corp. (PSCR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 79 filings and access original documents at no cost. Proto Script Pharmaceutical Corp.'s CIK is 0001521420.

PSCR SEC filingsProto Script Pharmaceutical Corp. SEC documentsfind PSCR 10-K